Natascha Vidovic

Dr. Natascha Vidovic


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 November 2015 in Cell Death & Differentiation
Verified
Journal Article
Closed access
MRM Richter
M Richter
NVNatascha Vidovic
Natascha Vidovic
BHB Honrath
B Honrath
PMP Mahavadi
P Mahavadi
RDR Dodel
R Dodel
Carsten CulmseeCarsten Culmsee
Carsten Culmsee

26 November 2019 in Brain Pathology
Verified
Journal Article
Open access
PDF file
MRMaren Richter
Maren Richter
NVNatascha Vidovic
Natascha Vidovic
KBKnut Biber
Knut Biber
ADAmalia Dolga
Amalia Dolga
Carsten CulmseeCarsten Culmsee
Carsten Culmsee
RDRichard Dodel
Richard Dodel
During Alzheimer’s disease (AD) progression, microglial cells play complex roles and have potentially detrimental as well as beneficial effects. The use of appropriate model systems is essential for characterizing and understanding the roles of microglia in AD pathology. Here, we used organotypic hippocampal slice cultures (OHSCs) to investigate the impact of microglia on amyloid beta (Aβ)‐mediated toxicity. Neurons in OHSCs containing microglia were not vulnerable to cell death after 7 days of repeated treatment with Aβ1‐42 oligomer‐enriched preparations. However, when clodronate was used to remove microglia, treatment with Aβ1‐42 resulted in significant neuronal death. Further investigations indicated signs of endoplasmic reticulum stress and caspase activation after Aβ1‐42 challenge only when microglia were absent. Interestingly, microglia provided protection without displaying any classic signs of activation, such as an amoeboid morphology or the release of pro‐inflammatory mediators (e.g., IL‐6, TNF‐α, NO). Furthermore, depleting microglia or inhibiting microglial uptake mechanisms resulted in significant more Aβ deposition compared to that observed in OHSCs containing functional microglia, suggesting that microglia efficiently cleared Aβ. Because inhibiting microglial uptake increased neuronal cell death, the ability of microglia to engulf Aβ is thought to contribute to its protective properties. Our study argues for a beneficial role of functional ramified microglia whereby they act against the accumulation of neurotoxic forms of Aβ and support neuronal resilience in an in situ model of AD pathology.

Verified
Journal Article
Open access
PDF file
NVNatascha Vidovic
Natascha Vidovic
BSBjörn Spittau
Björn Spittau
Novel technologies such as single-cell RNA and single-nucleus RNA sequencing have shed new light on the complexity of different microglia populations in physiological and pathological states. The transcriptomic profiling of these populations has led to the subclassification of specific disease-associated microglia and microglia clusters in neurodegenerative diseases. A common profile includes the downregulation of homeostasis and the upregulation of inflammatory markers. Furthermore, there is concordance in few clusters between murine and human samples. Apolipoprotein E, which has long been considered a high-risk factor for late-onset Alzheimer’s disease, is strongly regulated in both these murine and human clusters. Transforming growth factor-β plays an essential role during the development and maturation of microglia. In a pathological state, it attenuates their activation and is involved in numerous cell regulatory processes. Transforming growth factor-β also has an influence on the deposition of amyloid-beta, as it is involved in the regulation of key proteins and molecules. Taken together, this review highlights the complex interaction of apolipoprotein E, the triggering receptor on myeloid cells 2, and transforming growth factor-β as part of a regulatory axis in microglia at the onset and over the course of Alzheimer’s disease.

4 April 2024 in Cells
Verified
Journal Article
Open access
PDF file
PPPhani Sankar Potru
Phani Sankar Potru
NVNatascha Vidovic
Natascha Vidovic
SWSusanne Wiemann
Susanne Wiemann
TRTamara Russ
Tamara Russ
MTMarcel Trautmann
Marcel Trautmann
BSBjörn Spittau
Björn Spittau
Despite being immune cells of the central nervous system (CNS), microglia contribute to CNS development, maturation, and homeostasis, and microglia dysfunction has been implicated in several neurological disorders. Recent advancements in single-cell studies have uncovered unique microglia-specific gene expression. However, there is a need for a simple yet elegant multiplexed approach to quantifying microglia gene expression. To address this, we have designed a NanoString nCounter technology-based murine microglia-specific custom codeset comprising 178 genes. We analyzed RNA extracted from ex vivo adult mouse microglia, primary mouse microglia, the BV2 microglia cell line, and mouse bone marrow monocytes using our custom panel. Our findings reveal a pattern where homeostatic genes exhibit heightened expression in adult microglia, followed by primary cells, and are absent in BV2 cells, while reactive markers are elevated in primary microglia and BV2 cells. Analysis of publicly available data sets for the genes present in the panel revealed that the panel could reliably reflect the changes in microglia gene expression in response to various factors. These findings highlight that the microglia panel used offers a swift and cost-effective means to assess microglial cells and can be used to study them in varying contexts, ranging from normal homeostasis to disease models.

1 May 2021 in Neuroscience
Verified
Journal Article
Closed access
AAAlexandra Albus
Alexandra Albus
YKYannick Kronimus
Yannick Kronimus
SNSascha Neumann
Sascha Neumann
NVNatascha Vidovic
Natascha Vidovic
AFAndré Frenzel
André Frenzel
RDRichard Dodel
Richard Dodel

4 February 2026 in Biomolecules
Verified
Journal Article
Open access
PDF file
OKOliver Krzyzan
Oliver Krzyzan
AKAngela Kuhla
Angela Kuhla
BSBjörn Spittau
Björn Spittau
NVNatascha Vidovic
Natascha Vidovic
Aging and Alzheimer’s disease (AD) are associated with profound changes in glial cell morphology and signaling. This study investigates the three-dimensional morphology of microglia and the intracellular localization of phosphorylated SMAD proteins as downstream effectors of transforming growth factor β (TGF-β) signaling in the amyloid precursor protein and presenilin-1 (APP/PS1) transgenic mouse model of Alzheimer’s disease. Using confocal microscopy and Simple Neurite Tracer software, we reconstructed and quantitatively analyzed glial cell morphology in aged wild-type and APP/PS1 mice. Immunofluorescence staining revealed altered pSMAD2 distribution in microglia, suggesting impaired canonical TGF-β signaling. Our findings indicate a disturbed glial morphology and dysfunctional TGF-β signaling cascade in the APP/PS1 model, underlining their potential role in Alzheimer’s disease pathogenesis.